247 related articles for article (PubMed ID: 24893317)
21. [Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease].
Allegri RF; Russo MJ; Kremer J; Taragano FE; Brusco I; Ollari JA; Serrano CM; Sarasola D; Demey I; Arizaga RL; Bagnati P
Vertex; 2012; 23(101):5-15. PubMed ID: 22880190
[TBL] [Abstract][Full Text] [Related]
22. Considerations for mood and emotion measures in mindfulness-based intervention research.
Hoge EA; Philip SR; Fulwiler C
Curr Opin Psychol; 2019 Aug; 28():279-284. PubMed ID: 30995594
[TBL] [Abstract][Full Text] [Related]
23. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB
J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460
[TBL] [Abstract][Full Text] [Related]
24. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
[TBL] [Abstract][Full Text] [Related]
25. Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.
Auning E; Selnes P; Grambaite R; Šaltytė Benth J; Haram A; Løvli Stav A; Bjørnerud A; Hessen E; Hol PK; Muftuler løndalen A; Fladby T; Aarsland D
Acta Psychiatr Scand; 2015 Feb; 131(2):139-47. PubMed ID: 25346330
[TBL] [Abstract][Full Text] [Related]
26. White matter hyperintensities are positively associated with cortical thickness in Alzheimer's disease.
Jacobs HI; Clerx L; Gronenschild EH; Aalten P; Verhey FR
J Alzheimers Dis; 2014; 39(2):409-22. PubMed ID: 24169238
[TBL] [Abstract][Full Text] [Related]
27. Systematic review of strengths and limitations of randomized controlled trials for non-pharmacological interventions in mild cognitive impairment: focus on Alzheimer's disease.
Horr T; Messinger-Rapport B; Pillai JA
J Nutr Health Aging; 2015 Feb; 19(2):141-53. PubMed ID: 25651439
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome, mild cognitive impairment and Alzheimer's disease--the emerging role of systemic low-grade inflammation and adiposity.
Misiak B; Leszek J; Kiejna A
Brain Res Bull; 2012 Nov; 89(3-4):144-9. PubMed ID: 22921944
[TBL] [Abstract][Full Text] [Related]
29. The economics of mild cognitive impairment.
Lin PJ; Neumann PJ
Alzheimers Dement; 2013 Jan; 9(1):58-62. PubMed ID: 23141385
[TBL] [Abstract][Full Text] [Related]
30. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
31. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects.
Richard E; Schmand B; Eikelenboom P; Yang SC; Ligthart SA; Moll van Charante EP; van Gool WA;
Dement Geriatr Cogn Disord; 2012; 33(2-3):204-9. PubMed ID: 22722671
[TBL] [Abstract][Full Text] [Related]
32. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
[TBL] [Abstract][Full Text] [Related]
33. Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment.
Spalletta G; Girardi P; Caltagirone C; Orfei MD
J Alzheimers Dis; 2012; 29(4):761-72. PubMed ID: 22349686
[TBL] [Abstract][Full Text] [Related]
34. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
35. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
[TBL] [Abstract][Full Text] [Related]
36. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
[TBL] [Abstract][Full Text] [Related]
38. Female dominant association of sarcopenia and physical frailty in mild cognitive impairment and Alzheimer's disease.
Ohta Y; Nomura E; Hatanaka N; Osakada Y; Matsumoto N; Sasaki R; Tsunoda K; Takemoto M; Tadokoro K; Hishikawa N; Wakutani Y; Yamashita T; Sato K; Omote Y; Abe K
J Clin Neurosci; 2019 Dec; 70():96-101. PubMed ID: 31444048
[TBL] [Abstract][Full Text] [Related]
39. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
40. In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease.
Solodkin A; Chen EE; Van Hoesen GW; Heimer L; Shereen A; Kruggel F; Mastrianni J
J Comp Neurol; 2013 Dec; 521(18):4300-17. PubMed ID: 23839862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
